SCHEMBL4654293

SCHEMBL4654293

CON(C)C(=O)c1sc2cc(C(F)(F)F)ccc2c1C

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.42
DYRK1A Q13627 2/20 0.40
CLK1 P49759 1/20 0.40
DYRK1B Q9Y463 1/20 0.40
CES2 O00748 1/20 0.39
TRPM8 Q7Z2W7 2/20 0.37
CSNK1D P48730 2/20 0.36
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ESR1 P03372 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CFTR P13569 1/20 0.35
CISD2 Q8N5K1 1/20 0.34
ICAM1 P05362 1/20 0.34
SELE P16581 1/20 0.34
GPR35 Q9HC97 1/20 0.34
PPARA Q07869 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4656300 0.90 DYRK1A (0.42) MLYCDDYRK1ACLK1DYRK1BTRPM8
SCHEMBL4654201 0.83 TRPM8 (0.46) DYRK1ACLK1DYRK1BCES2TRPM8
SCHEMBL717432 0.82 ALDH1A1 (0.48) DYRK1ACES2CSNK1DMEN1KMT2A
SCHEMBL4654240 0.82 CES2 (0.56) DYRK1ACLK1DYRK1BCES2ALDH1A1
SCHEMBL6840332 0.80 DYRK1A (0.44) DYRK1ACES2CSNK1DMEN1KMT2A
SCHEMBL2721181 0.80 GPR35 (0.54) DYRK1AMEN1KMT2AESR1ALDH1A1
SCHEMBL6840329 0.79 MEN1 (0.40) DYRK1ACES2CSNK1DMEN1KMT2A
SCHEMBL4656277 0.77 KDM4E (0.38) DYRK1ACES2CSNK1DMEN1KMT2A
SCHEMBL4657231 0.75 GSK3B (0.40) DYRK1ACES2TRPM8CSNK1DMEN1
SCHEMBL4655214 0.75 MEN1 (0.38) DYRK1ACES2CSNK1DMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740568-B1 BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL FOR THE TREATMENT OF CARDIOVASCULAR DISEASE. SMITHKLINE BEECHAM CORP (US) 2008-11-26 EP disclosed
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease SMITHKLINE BEECHAM CORPORATION 2007-07-05 US disclosed
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease SMITHKLINE BEECHAM CORPORATION 2007-07-05 US disclosed
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease SMITHKLINE BEECHAM CORPORATION 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease ABAT, BPTF, TNNT2 MLYCD 1125/4885DYRK1A 4470/4885CLK1 4746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.